Our results also revealed that the GREM1-MMP13 signaling pathway was triggered by activation of STAT3, suggesting that the GREM1-STAT3-MMP13 axis might be a new therapeutic target for breast cancer metastasis. This evidence concerns the gene MMP13 and breast carcinoma.